Overview

Two-channel IV-PCA With Dexmedetomidine

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Dexmedetomidine was administered in the 'selector' channel and fentanyl in the 'basic & bolus' channel of dual channel intravenous patient-controlled analgesia (IV-PCA) and the amount of opioid consumption was compared. In addition, intensity of pain, postoperative nausea/vomiting, and postoperative delirium was evaluated.
Phase:
N/A
Details
Lead Sponsor:
Korea University Guro Hospital
Treatments:
Dexmedetomidine